Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment

被引:48
|
作者
Kwon, Jin-Woo [1 ]
Jee, Donghyun [1 ]
机构
[1] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, Kyunggi Do, South Korea
来源
PLOS ONE | 2018年 / 13卷 / 09期
基金
新加坡国家研究基金会;
关键词
ENDOTHELIAL-CELL PERMEABILITY; RANDOMIZED CLINICAL-TRIAL; RETINAL VEIN OCCLUSION; INTRAVITREAL BEVACIZUMAB; KAPPA-B; RETINOPATHY; DEXAMETHASONE; INTERLEUKIN-8; PREVALENCE; IL-10;
D O I
10.1371/journal.pone.0203408
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose To determine aqueous cytokines association with response to intravitreal bevacizumab (IVB) injection in diabetic macular edema (DME). Method We compared the concentrations of IL (interleukin)-1 beta, 1L-2, IL-8, IL-10, IL-17, placental growth factor (PIGF), and vascular endothelial growth factor (VEGF) in the aqueous humor of 64 naive DME patients with those of 13 cataract patients. Factors associated with central subfield thickness (CST) in DME patients were identified. DME patients were then sub-grouped in terms of responsiveness to three IVB injections; cytokine concentrations were compared, and factors associated with responsiveness were identified. Results Levels of IL-2, IL-8, PIGF, and VEGF were significantly elevated in DME patients (p = 0.007, p < 0.001, p < 0.001, and p = 0.004 respectively). Regression analysis showed that the preoperative CST was associated with the preoperative best-corrected visual acuity and the aqueous IL-10 level (p < 0.001, p = 0.006, respectively). Of the 64 DME patients, 28 (43.75%) exhibited either CST < 300 mu m or reduction in CST >= 50 mu m after three consecutive IVB injections. On sub-group analysis, the mean IL-8 concentration was higher in the refractory group than in the responsive group, and multivariate logistic regression analysis showed that the IL-8 was the only factor associated with responsiveness (OR = 0.95, p = 0.017). Conclusions The IL-8 concentration in the aqueous humor was associated with responsiveness to IVB in DME patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema
    Oshima, Hideyuki
    Takamura, Yoshihiro
    Hirano, Takao
    Shimura, Masahiko
    Sugimoto, Masahiko
    Kida, Teruyo
    Matsumura, Takehiro
    Gozawa, Makoto
    Yamada, Yutaka
    Morioka, Masakazu
    Inatani, Masaru
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
  • [42] Outer retinal tubulation in diabetic macular edema following anti-VEGF treatment
    Ali M Al-Halafi
    Eye and Vision, 2
  • [43] Outer retinal tubulation in diabetic macular edema following anti-VEGF treatment
    Al-Halafi, Ali M.
    EYE AND VISION, 2015, 2
  • [44] VEGF Levels in Aqueous: A Predictive Biomarker in the Treatment of Diabetic Macular Edema
    Kochhar, Shivani
    Mynampati, Bharani Krishna
    Ghulam, Shabbir Hamdani
    Bell, Kerry
    WuDunn, Darrell
    Grover, Sandeep
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [45] A real-world study for timely assessing the diabetic macular edema refractory to intravitreal anti-VEGF treatment
    Hsieh, Tsung-Cheng
    Deng, Guang-Hong
    Chang, Yung-Ching
    Chang, Fang-Ling
    He, Ming-Shan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [46] Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy
    Nalcaci, Serhad
    Akkin, Cezmi
    Afrashi, Filiz
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2019, 49 (02): : 73 - 77
  • [47] Compliance and adherence of patients with diabetic macular edema to intravitreal Anti-VEGF therapy
    Weiss, Maximilian
    Herold, Tina
    Schumann, Ricarda
    Liegl, Raffael
    Muller, Michael
    Babenko, Alexander
    Rottmann, Miriam
    Schiefelbein, Johannes
    Priglinger, Siegfried
    Kortuem, Karsten Ulrich
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [48] Hyperuricemia is associated with anti-VEGF response in patients with diabetic macular edema.
    Chen, Yun Wen
    Chiang, Wei-Yu
    Lee, Jon-Jer
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [49] Predictive Value of Macular Thickness Fluctuations on Response to Anti-VEGF Treatment in Diabetic Macular Edema
    Alam, Taseen
    Das, Nikhil
    Maatouk, Christopher
    Singh, Rishi
    Talcott, Katherine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [50] Anti-VEGF Therapy Reduces Inflammation in Diabetic Macular Edema
    Imazeki, Makoto
    Noma, Hidetaka
    Yasuda, Kanako
    Motohashi, Ryosuke
    Goto, Hiroshi
    Shimura, Masahiko
    OPHTHALMIC RESEARCH, 2021, 64 (01) : 43 - 49